Glenmede Trust CO Na Abbott Laboratories Transaction History

Glenmede Trust CO Na

$18.2 Billion
Q1 2025

A detailed history of Glenmede Trust CO Na transactions in Abbott Laboratories stock. As of the latest transaction made, Glenmede Trust CO Na holds 1,309,315 shares of ABT stock, worth $173 Million. This represents 0.96% of its overall portfolio holdings.

Number of Shares

1,309,315

Previous 1,365,452 4.11%

Holding current value

$173 Million

Previous $154 Million 12.45%

% of portfolio

0.96%

Previous 0.81%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 15, 2025	SELL	$111.1 - $140.22 $6.24 Million - $7.87 Million	-56,137 Reduced 4.11%	1,309,315 $174 Million
Q4 2024 Feb 14, 2025	SELL	$111.93 - $119.39 $16.9 Million - $18.1 Million	-151,393 Reduced 9.98%	1,365,452 $154 Million
Q3 2024 Nov 13, 2024	SELL	$100.07 - $118.13 $1.93 Million - $2.28 Million	-19,297 Reduced 1.26%	1,516,845 $173 Million
Q2 2024 Aug 14, 2024	BUY	$100.73 - $112.44 $1.29 Million - $1.44 Million	12,792 Added 0.84%	1,536,142 $160 Million
Q1 2024 May 15, 2024	BUY	$109.52 - $120.96 $2.7 Million - $2.98 Million	24,670 Added 1.65%	1,523,350 $173 Million
Q4 2023 Feb 13, 2024	BUY	$90.19 - $110.4 $1.76 Million - $2.15 Million	19,496 Added 1.32%	1,498,680 $165 Million
Q3 2023 Nov 14, 2023	SELL	$95.53 - $114.62 $18.8 Million - $22.6 Million	-197,156 Reduced 11.76%	1,479,184 $143 Million
Q1 2023 May 15, 2023	SELL	$96.86 - $114.01 $5.51 Million - $6.49 Million	-56,922 Reduced 3.28%	1,676,340 $170 Million
Q4 2022 Feb 14, 2023	BUY	$95.06 - $111.52 $29.4 Million - $34.4 Million	308,787 Added 21.68%	1,733,262 $190 Million
Q3 2022 Nov 16, 2022	SELL	$96.76 - $112.03 $19.6 Million - $22.7 Million	-202,573 Reduced 12.45%	1,424,475 $138 Million
Q2 2022 Aug 15, 2022	BUY	$102.07 - $123.37 $28.5 Million - $34.4 Million	278,957 Added 20.69%	1,627,048 $177 Million
Q1 2022 May 16, 2022	BUY	$114.02 - $139.04 $3.24 Million - $3.95 Million	28,416 Added 2.15%	1,348,091 $160 Million
Q4 2021 Feb 15, 2022	SELL	$115.53 - $141.46 $596,019 - $729,792	-5,159 Reduced 0.39%	1,319,675 $186 Million
Q3 2021 Nov 15, 2021	BUY	$116.66 - $129.06 $30,098 - $33,297	258 Added 0.02%	1,324,834 $157 Million
Q2 2021 Aug 16, 2021	BUY	$105.79 - $124.53 $1.27 Million - $1.49 Million	11,991 Added 0.91%	1,324,576 $154 Million
Q1 2021 May 18, 2021	BUY	$108.84 - $128.23 $10 Million - $11.8 Million	91,965 Added 7.53%	1,312,585 $157 Million
Q4 2020 Feb 16, 2021	SELL	$105.0 - $114.42 $3.93 Million - $4.28 Million	-37,418 Reduced 2.97%	1,220,620 $134 Million
Q3 2020 Nov 16, 2020	BUY	$91.64 - $111.29 $1.38 Million - $1.68 Million	15,066 Added 1.21%	1,258,038 $137 Million
Q2 2020 Aug 14, 2020	BUY	$76.57 - $98.0 $1.73 Million - $2.21 Million	22,566 Added 1.85%	1,242,972 $114 Million
Q4 2019 Feb 12, 2020	BUY	$78.51 - $87.4 $2.53 Million - $2.82 Million	32,253 Added 2.71%	1,220,406 $106 Million
Q3 2019 Nov 14, 2019	SELL	$81.84 - $88.74 $6.52 Million - $7.07 Million	-79,688 Reduced 6.29%	1,188,153 $99.4 Million
Q2 2019 Aug 13, 2019	SELL	$72.88 - $85.0 $3.15 Million - $3.67 Million	-43,235 Reduced 3.3%	1,267,841 $107 Million
Q1 2019 May 14, 2019	SELL	$66.22 - $80.06 $368,050 - $444,973	-5,558 Reduced 0.42%	1,311,076 $105 Million
Q4 2018 Feb 14, 2019	SELL	$65.56 - $74.27 $870,571 - $986,231	-13,279 Reduced 1.0%	1,316,634 $95.2 Million
Q3 2018 Nov 15, 2018	SELL	$60.81 - $73.36 $661,856 - $798,450	-10,884 Reduced 0.81%	1,329,913 $97.6 Million
Q2 2018 Aug 15, 2018	SELL	$57.57 - $63.54 $12.7 Million - $14 Million	-220,303 Reduced 14.11%	1,340,797 $81.8 Million
Q4 2017 Feb 15, 2018	SELL	$53.68 - $57.47 $705,194 - $754,983	-13,137 Reduced 0.83%	1,561,100 $89.1 Million
Q3 2017 Nov 14, 2017	BUY	$48.06 - $53.64 $75.7 Million - $84.4 Million	1,574,237	1,574,237 $0

Others Institutions Holding ABT

# of Institutions

3,540

Shares Held

1.38B

Call Options Held

9.75M

Put Options Held

8.87M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $231B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Glenmede Trust CO Na, based on Form 13F filings with the SEC.

News

Stay updated on Glenmede Trust CO Na with notifications on news.

Account

Glenmede Trust CO Na Abbott Laboratories Transaction History